Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2025 07:00 ET | Source: Causeway Therapeutics Ltd

Causeway Therapeutics Debuts Positive Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis

Causeway Therapeutics announces positive data from its Phase 2 clinical trial of TenoMiR® for lateral epicondylitis.